SKI Market

Indian Indices

Sensex

78,205.98 639.82
( 0.82%)

Global Indices

Nasdaq

47,737.88 215.33
(0.45%)

Dow Jones

6,814.47 53.45
(0.79%)

Hang Seng

54,146.56 1,417.84
(2.69%)

Nikkei 225

10,249.54 -35.21
(-0.34%)

Forex

USD-INR

91.85 0.10
(0.11%)

EUR-INR

106.60 0.13
(0.12%)

GBP-INR

123.04 0.62
(0.51%)

JPY-INR

0.58 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Ipca Laboratories consolidated net profit rises 23.13% in the September 2025 quarter

Nov 13,2025

Net profit of Ipca Laboratories rose 23.13% to Rs 282.57 crore in the quarter ended September 2025 as against Rs 229.48 crore during the previous quarter ended September 2024. Sales rose 8.56% to Rs 2556.50 crore in the quarter ended September 2025 as against Rs 2354.90 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2556.50	2354.90	9
OPM %	21.32	18.75	-
PBDT	553.17	445.18	24
PBT	449.84	344.83	30
NP	282.57	229.48	23

78,205.98 639.82 ( 0.82%)

47,737.88 215.33 (0.45%)

6,814.47 53.45 (0.79%)

54,146.56 1,417.84 (2.69%)

10,249.54 -35.21 (-0.34%)

91.85 0.10 (0.11%)

106.60 0.13 (0.12%)

123.04 0.62 (0.51%)

0.58 0.00 (-0.25%)